IP84: Kidney Cancer: Basic Research & Pathophysiology
Monday, May 18, 2026 9:30 AM to 11:30 AM · 2 hr. (America/New_York)
147B
Poster and Podium Sessions
Basic Science ResearchOncology: Kidney
Information
Of Interest To
Researchers
Monday, May 18
IP84-01: Comparative transcriptome atlas facilitates molecular classification of diverse kidney cancers
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-02: Spatial transcriptomic profiling of TSC-associated angiomyolipoma reveals molecular heterogeneity distinct from sporadic AML
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-03: Loss of Y and X chromosomes differentially predicts outcomes and are associated with DNA methylation age in male patients with kidney renal papillary cell carcinoma
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-04: Comparative Analysis of VHL Gene Mutations in Patients with Von Hippel–Lindau Syndrome and Sporadic Clear Cell Renal Cell Carcinoma
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-05: Primary cilia-hedgehog pathway regulates autophagy and malignant progression of papillary renal cell carcinoma
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-06: Deregulation of spindle assembly checkpoints via TRIP13 upregulation leads to loss of heterozygosity in aggressive chromophobe renal cell carcinoma and may be a promising therapeutic target
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-07: FGD1 Splice Variant in Clear Cell Renal Cell Carcinoma is a Novel Biomarker for Inferior Clinical Outcomes and Development of Brain and Bone Metastasis.
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
Kendrick Yim · Moffitt Cancer Center
IP84-08: CTNNA1 (aE-catenin) promotes invasion and migration in clear cell renal cell carcinoma via N-cadherin–dependent adhesion and RhoA modulation
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-09: Pathological Characteristics and Clinical Features of the Borderline Region in Renal Cell Carcinoma: Exploring Mechanisms of Tumor Invasion and Metastasis
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-10: Critical involvement of PRELID2 in the regulation of mitochondrial homeostasis in renal carcinogenesis
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-11: Obesity Worsens Mitochondrial Dysfunction in Human Clear Cell Renal Cell Carcinoma
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-12: SREBP1-Activated Lipid Metabolism Drives Ferroptosis and Progression of Clear Cell Renal Cell Carcinoma
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
Pengfei Shao
IP84-13: Vascular PSMA expression drives angiogenesis and recurrence in renal cell carcinoma and represents a rationale for PSMA-targeted therapy
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-14: Immunoglobulin J chain in tumor vasculature as a key inducer of activated CD8? T cells in the tumor microenvironment of kidney cancer and contributes to the response to immune checkpoint inhibitor combinations
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-15: Enriched YES1 tumor expression at the stromal interface is associated with worse overall survival in clear cell renal cell carcinoma when treated with first-line immune checkpoint blockade
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-16: Integrative Analysis of Senescence-Associated miRNAs Reveals Prognostic and Immune-Regulatory Mechanisms in Clear Cell Renal Cell Carcinoma
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
Zheng Song
IP84-17: Comparative Prognostic Performance of KEYNOTE-564 and AUA Risk Stratification in Non-Metastatic Clear Cell Renal Cell Carcinoma
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
Nicolomaria Buffi
IP84-18: Markers of systemic immune activation do not predict tumor response based on immune related residual viable tumor (%irRVT)
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-19: Combinatorial Immunotherapy with IL-12/shVEGF-Expressing Oncolytic Adenovirus for Renal Cell Carcinoma: In Vitro, Organ-on-a-Chip, and In Vivo Evaluation
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-20: Discovery of a Nuclear-Active TBK1 Inhibitor Targeting Synthetic Lethality in VHL-Deficient Renal Cell Carcinoma
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
Zheng Song
IP84-21: COL2A1 as a Novel Therapeutic Target in High-Risk Wilms Tumor
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-22: Discovery of an epigenetic marker panel for the non-invasive detection of renal cell carcinoma: Potential for a future urinary liquid biopsy
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-23: Urine-derived tumor extracellular vesicles for non-invasive diagnosis of clear-cell renal cell carcinoma
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-24: Extracellular Vesicle-Bound Fraction of Kidney Injury Molecule 1 is a promising blood-based marker of clear-cell renal cell carcinoma
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-25: Development and Validation of a Mouse-Derived Cancer-a-Chip Model for Drug Screening in Renal Cell Carcinoma
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-26: Multi-Institutional Evaluation of AI in Identifying Rhabdoid Features of Clear Cell Renal Cell Carcinoma
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
Yamlak Bogale
IP84-27: Cohesion-Interfacial Enhanced Adhesive Hydrogel Patch for Hemostasis and Tissue Injury Repair After Partial Nephrectomy
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
IP84-28: Liquid biopsy in Renal Cell Carcinoma: diagnostic potential of urinary miRNAs
Monday, May 18, 2026 9:30 AM to 11:30 AM
147B
